Cargando…
Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases
Autores principales: | Hellmers, Natalie, Obeng-Aduasare, Yaa, de Melo-Martín, Inmaculada, Henchcliffe, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774238/ https://www.ncbi.nlm.nih.gov/pubmed/26981090 http://dx.doi.org/10.4103/1673-5374.169632 |
Ejemplares similares
-
To Consent or Not to Consent to Screening, That Is the Question
por: Hofmann, Bjørn
Publicado: (2023) -
Waivers of informed consent in research with competent participants and the Declaration of Helsinki
por: Dal-Ré, Rafael
Publicado: (2023) -
Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease
por: Cardozo, Timothy, et al.
Publicado: (2020) -
Obtaining Consent for Future Research with Induced Pluripotent Cells: Opportunities and Challenges
por: Aalto-Setälä, Katriina, et al.
Publicado: (2009) -
Informed Consent for Endoscopic Biliary Drainage: Time for a New Paradigm
por: Spadaccini, Marco, et al.
Publicado: (2022)